News
ICMR announces expansion for India Hypertension Control Initiative
ICMR’s program will now cover 100 districts across India. The project will accelerate the implementation of quality hypertension treatment for over 15 crore population over the next four years and prevent deaths from heart attack.
NIH-developed experimental respiratory syncytial virus vaccine shows early promise in Phase 1 trials
An interim analysis of study data showed that one dose of the investigational vaccine prompted large increases in RSV-neutralizing antibodies that were sustained for several months.
